Choosing the correct treatment for acute aortic type B dissection.

Area of Science:

• Cardiovascular Surgery
• Vascular Medicine
• Thoracic Surgery

Background:

• Acute type B aortic dissection presents a significant clinical challenge due to varied symptoms and treatment uncertainties.
• Medical management is standard for uncomplicated cases, while surgical or endovascular options are reserved for complications.
• Complicated dissections, occurring in 25% of patients, involve malperfusion, rupture, or uncontrolled hypertension.

Purpose of the Study:

• To evaluate the evolving treatment strategies for acute type B aortic dissection.
• To assess the role of thoracic endovascular aortic repair (TEVAR) in managing complicated dissections.
• To explore the potential benefits of early TEVAR for long-term outcomes.

Main Methods:

• Review of current medical literature and clinical practice trends.
• Analysis of outcomes associated with medical management versus endovascular intervention.
• Examination of data supporting early TEVAR for acute type B aortic dissection.

Main Results:

• Thoracic endovascular aortic repair (TEVAR) is increasingly favored for complicated acute type B dissections due to lower morbidity and mortality.
• While medical therapy is standard for uncomplicated cases, it does not prevent long-term aortic complications.
• Emerging data suggest early TEVAR may reduce aortic events and improve survival by addressing the entry tear and promoting remodeling.

Conclusions:

• A paradigm shift towards early TEVAR for acute type B aortic dissection is evident, particularly for complicated cases.
• TEVAR offers advantages in managing complications and potentially improving long-term aortic health.
• Further research is needed to solidify optimal treatment strategies, but current trends favor early intervention in select patients.